A RAPIDLY GROWING DRUG CLASS WITH GREAT POTENTIAL

Oligonucleotides have rapidly gained momentum as a class of biotherapeutics presenting complex challenges in the commercialization of gene therapies. Learn how our unique platform can help you rapidly propel through the development process.

GT Webinar 1 SP

WATCH OUR WEBINAR


EXPERIENCE MATTERS

In the rapidly developing field of gene therapy, Pace® is considered an experienced veteran. Since 2015 we have worked closely with our customer-partners to accelerate processes and provide support throughout the gene therapy product development cycle.

 

PACE Pharmaceutical & Biopharmaceutical Product Development

Pace_GeneTherapy_LandingPage_100721

 


Have questions about a new project?

 

Give Us A Call

(612) 656-2291